Recommended as Stock of the Week on March 9, 2026

Fortive: The silent precision maker that hardly anyone knows - but many need

TickerFTV.NYSE
Recommended Price55.66 USD
Current Price 55.66 USD
Fortive Corp – stock chart

Scores at time of recommendation (March 9, 2026)

Leeway Score
60/100
Excellent
Business Rating
72/100
Excellent
Market-Fit Rating
58/100
Excellent
Cycle Rating
52/100
Fair

More about our scores in Help

5-year stock timeline

2026-07-29 — Q2 2026 results; guidance raised

Fortive reported Q2 2026 results that beat consensus and raised full‑year adjusted EPS guidance to $2.95–$3.05. Management highlighted accelerating core revenue growth and reiterated its margin expansion framework. [1][4]

Investor perception shifted toward renewed confidence in Fortive's earnings trajectory after the spin‑offs and portfolio refinements. The narrative moved from stabilization to execution and margin leverage, with analysts broadly viewing the raise as validation of the company's margin program and organic momentum. [1][3]

The stock rallied following the beat and guidance lift, moving from range into an upward trend on the news. [4]

2026 Q1 (April 30, 2026) — Q1 2026 beat and guidance reaffirmation

Fortive reported Q1 2026 adjusted EPS of $0.70 (beat) and reaffirmed full‑year adjusted EPS guidance of $2.90–$3.00, noting results were trending to the upper half of the range. Core revenue and adjusted EBITDA showed solid growth. [6][7]

The results reinforced the buy‑and‑improve thesis: investors saw consistent execution on growth and margin expansion targets after portfolio simplification, supporting expectations for a higher‑quality industrial compounder. [7]

The stock consolidated with mild upward bias following the report, with guidance holding and a bullish tilt toward breakout. [6]

2025-06-28 — Completion of Ralliant spin‑off (Precision Technologies) and leadership appointment

Fortive completed the spin‑off of its Precision Technologies segment as Ralliant Corporation (RAL) via a 1-for-3 distribution to Fortive shareholders on June 28, 2025. The company also named Olumide Soroye as President & CEO and director of Fortive in connection with the separation. [15]

The market treated the separation as a deliberate portfolio simplification—one more step in Fortive's multi‑year reshaping. Fortive repositioned as a more focused, higher‑margin industrial technology and instrumentation company, with Ralliant's IPO allowing investors to value Precision Technologies assets separately. Some investors viewed Fortive as a leaner compounder; others worried about near‑term EPS dilution from transaction costs and re‑rating risks. [15][12]

The stock experienced volatility and a short drawdown around the separation date, followed by stabilization and renewed uptrend as the market digested the spin‑off. [15]

2024 (throughout year) — Portfolio realignments and divestitures

Fortive completed the divestiture of Invetech (excluding retained Motion Solution Business) to management in June 2024 and performed segment realignments in early 2024 as part of preparing the Precision Technologies separation. [14]

Investors viewed these as housekeeping moves to tidy business lines ahead of the PT spin‑off. The company emphasized tightening focus on higher‑return platforms and recurring software‑enabled revenues. Sentiment was constructive but watchful for one‑time charges and separation execution risk. [14]

The stock ranged to modestly positive as the market priced in future separation benefits, with intermittent rallies on confirmatory execution news. [14]

2024 Q1–Q2 — Execution toward separation and M&A integration

Fortive integrated acquisitions and prepared the PT separation, continuing to execute margin improvement programs and targeting 50–100 basis points of annual EBITDA margin expansion. [12][1]

Operational discipline and active portfolio management became reinforced themes—investors increasingly rewarded visible margin progress and clarity on capital allocation. [12]

The stock moved in a gradual uptrend with periods of consolidation as investors awaited the formal separation timetable. [12]

2024 January 4 — EA Elektro‑Automatik acquisition closes

Fortive announced in October 2023 the agreement to acquire EA Elektro‑Automatik for $1.45 billion; the acquisition closed in early January 2024. EA added high‑power electronic test & measurement capabilities focused on energy storage, EV, and hydrogen applications. [16][18]

The market interpreted the acquisition as a strategic bolt‑on to Tektronix and test & measurement exposure—a move toward higher‑growth, electrification end markets. Investors generally saw the purchase as accretive to growth and margins if integration met expectations. [16][18]

The stock posted a positive price reaction on announcement followed by consolidation as integration and funding effects were evaluated. [16]

2023 October 23 — Announcement to acquire EA Elektro‑Automatik

Fortive announced a definitive agreement to acquire EA Elektro‑Automatik for $1.45 billion (net of tax benefit). Management framed it as accretive and complementary to Fortive's instrumentation businesses. [16][17]

The announcement strengthened the growth story focused on electrification and energy storage testing. Investors reacted favorably to higher‑quality end‑market exposure but priced in execution and financing risk. [16]

The stock posted an announcement‑driven uptick followed by short consolidation; acquisition news supported a secondary breakout while other macro factors held. [17]

2022–2023 — Post‑COVID normalization, margin focus, and acquisition activity

Fortive focused on margin improvement, executed targeted M&A and software investments (including prior 2021 ServiceChannel integration), and prepared larger strategic portfolio moves culminating in the EA deal and eventual PT separation planning. [19][16]

Investors came to view Fortive as an active portfolio manager executing a multi‑year transformation: spinning and selling non‑core assets while reinvesting in higher‑growth instrumentation, software, and service businesses. Sentiment moved from cyclical industrial to engineered‑growth industrial with a margin story. [19][16]

The stock recovered from 2020–2021 pandemic troughs in an uptrend, with bouts of volatility tied to M&A and macro reopening cycles. [19]

2021 August 24 — ServiceChannel acquisition completed

Fortive acquired ServiceChannel (SaaS facilities maintenance platform) on August 24, 2021, expanding recurring revenue exposure and software capabilities. [19][24]

The ServiceChannel deal signaled a clear tilt toward recurring‑revenue, software‑adjacent assets to diversify Fortive's industrial instrumentation base. Investors viewed this as structural improvement to revenue quality. [19]

The stock held an uptrend through 2021 on top‑line recovery and margin improvement; the acquisition was priced as strategic and supportive of a higher multiple over time. [19]

2021 (full year) — Strong financial performance and guidance momentum

Fortive reported strong 2021 results with adjusted EPS growth, robust free cash flow and margins, and raised full‑year 2021 guidance during the year as recovery continued post‑pandemic. [21][19]

After COVID disruption, the market narrative shifted to Fortive as a resilient industrial operator with solid cash generation and the balance sheet to pursue bolt‑on M&A and strategic separations. Confidence in management's active capital allocation rose. [21]

The stock posted a multi‑quarter uptrend during 2021 reflecting earnings recovery, with periodic pullbacks on macro risk but overall positive momentum. [19]

2021 and earlier — Prior spin‑offs and capital‑allocation track record

Fortive had earlier separated Vontier (October 2020) and executed prior portfolio actions; by 2021 management emphasized a playbook of spinning non‑core assets and executing targeted M&A. [25][19]

The company's track record of disciplined spin‑offs and portfolio reshaping established investor expectations that Fortive would continue to simplify and focus the company to drive higher returns. That credibility underpinned later market support for the Ralliant separation and strategic acquisitions. [25][19]

The stock's medium‑term trend improved as investors priced a clearer, more focused corporate structure. [25]

Key Points

From recommendation (March 9, 2026)

  • Q4 2025: Sales +4.6% to 1.12 billion USD, expectations exceeded by 2.7%
  • Adjusted EPS growth ~13% in the quarter, annual EPS guidance exceeded
  • Adjusted EBITDA growth ~8% in the quarter - solid operational execution
  • P/E ratio 31.6x at PEG of 0.98 - growth is not overpriced in the price
  • EPS estimates: USD 2.97 (2025e) → USD 3.18 (2026e) - moderate, steady growth
  • Gates Capital holds FTV as top 5 position with ~134.8m. USD exposure
  • Equity ratio solid at 55%, no balance sheet stress recognizable

Investment Thesis

From recommendation (March 9, 2026)

Fortive is not a glamor title - and that's exactly the point. The Group builds measurement technology, precision instruments and industrial software for customers who simply cannot afford to make mistakes. This creates high switching costs, stable margins and pricing power that is rare in the industry. Following the spin-off from Ralliant, Fortive is now more focused with two clear segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Q4 was further proof that the new structure is working. No hype, no moonshot - but a business model that delivers in difficult markets.

Key risks and downside factors

Fortive operates across instrumentation, sensing, industrial software, and healthcare sterilization. Its competitive landscape includes large diversified industrials alongside specialist firms in test and measurement, asset-management software, safety and gas detection, and healthcare sterilization. The company faces material headwinds from competitive intensity, technological disruption including AI, integration complexity from acquisitions, elevated leverage, and sensitivity to cyclical demand alongside supply-chain and regulatory friction.

  • Sustained competition across multiple product lines may necessitate price reductions, market share losses, or higher spending on R&D and sales to maintain customer relationships, as Fortive's 10-K filings acknowledge. [9]
  • Failure to develop, commercialize, or secure intellectual property protection for emerging technologies—including AI-enabled solutions—could undermine product competitiveness and limit growth prospects. [9]
  • Fortive relies heavily on acquisitions as a core strategic lever, though deals carry material risks around execution, balance sheet expansion, and the operational complexity of combining businesses. [9]
  • Cyclical swings in end-market demand, supply-chain bottlenecks, and regulatory or healthcare compliance requirements pose material risks to revenue, margins, and operational continuity. [9]

Competitive landscape

Fortive operates across industrial technology, precision instrumentation, test and measurement, healthcare sterilization, and vertical software. These markets contain both diversified industrials and specialist firms focused on instrumentation and software. Competition mainly comes from large diversified industrial companies and specialist vendors in test/measurement and healthcare equipment. The company faces material risks from supply-chain disruptions and commodity price swings, foreign-exchange and interest-rate movements, regulatory and medical-device compliance requirements, and execution challenges around acquisitions and software integration.

Private competitors

  • Rohde & Schwarz
  • Various regional/specialist test-and-measurement and sterilization equipment makers (undisclosed private firms)

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Catalysts

From recommendation (March 9, 2026)

  • 17. March: CFO appearance on J.P. Morgan Industrials Conference - Guidance and capital allocation signals
  • Next quarterly results: Confirmation of margin path after Group reorganization
  • M&A-Updates: Fortive has recently completed acquisitions - further portfolio measures possible
  • Macro: Stabilization in the industrial environment would support demand for measurement technology and automation solutions

Analysis

From recommendation (March 9, 2026)

Fortive's strength lies in the nature of its products: They are business-critical but account for only a small proportion of customers' total costs - a combination that facilitates price increases and structurally limits customers' bargaining power. Large industrial customers and institutions have aligned their processes with Fortive solutions, which makes a change complex and expensive. This advantage is reflected in an operating margin of around 20% - even if the EBIT margin has come under slight pressure from 18.7% (2023) to 16.4% (2025), which should be kept in mind. The net margins show a similar trend: from 14.3% (2023) to 11.3% (2025) - not an alarm signal, but an indication that the cost structure has not yet been fully optimized following the restructuring. The analysts' consensus vote is currently Hold, which signals a balanced risk/reward profile - no euphoria, but also no skepticism about the business model. Anyone looking for defensive industrial exposure with real pricing power and a PEG below 1 will find a solidly positioned stock here - without the expectation of a short-term revaluation upwards.

Performance Figures of Fortive Corp

in USD

1M High / Low
62.63 / 56.12
52W High / Low
64.56 / 47.01
5Y High / Low
87.07 / 46.34
1M
-7.62%
3M
-4.99%
6M
+4.08%
1Y
+19.34%
3Y
-1.16%
5Y
+2.01%

Relative Performance vs Benchmarks

PeriodFortive Corp vs DAX vs S&P 500 (SPY)
1M -7.62% -6.44% -7.22%
3M -4.99% -12.49% -11.43%
6M +4.08% -6.18% -12.17%
1Y +19.34% +10.09% -0.68%
3Y -1.16% -66.40% -80.60%
5Y +2.01% -64.47% -81.53%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current32.84.12.916.7
1Y ago21.12.61.610.7
3Y ago26.53.52.816.4
5Y ago11.23.82.816.4

Frequently Asked Questions

From recommendation (March 9, 2026)

Is Fortive Corp a good investment?

Fortive Corp has a Leeway Score of 60.5/100, which is rated as Excellent. The Leeway Score combines business quality, fundamental evaluation, and valuation cycle into a comprehensive assessment. A higher score indicates stronger investment quality based on AI-powered fundamental analysis.

What does Fortive Corp do?

Fortive Corp is a company characterized by the following investment thesis: Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington. Fortive Corp operates in the Technology / Scientific & Technical Instruments industry is based in USA employs around 10,000 people. Fortive Corp recently reported revenue of about 4.32B USD, a profit margin of 12.38%, return on equity of 7.32%, a market capitalisation around 17.36B USD, valuation multiples of roughly 30.1x earnings, 4x sales, 2.9x book value. Analyst consensus currently expects earnings per share of around 3.25 USD with year‑over‑year growth of 7.67%. Fortive Corp has an ongoing dividend policy and pays around 0.12 USD per share (0.21% yield).

What are the key metrics for FTV.NYSE?

Key metrics for FTV.NYSE include valuation (P/E 31.6, P/S 3.6, P/B 2.8), profitability (profit margin 13.93%, ROE 6.40%), and growth (revenue 4.60%, earnings -2.60%). Market capitalization is 18.53B USD. These metrics give an overview of the company's financial performance and valuation.

How has Fortive Corp's stock price performed?

Fortive Corp's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.

How is FTV.NYSE valued?

FTV.NYSE has the following valuation metrics: P/E Ratio: 31.6, P/S Ratio: 3.6, P/B Ratio: 2.8. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

What are the growth catalysts for Fortive Corp?

The key growth catalysts for Fortive Corp are:
  • 17. March: CFO appearance on J.P. Morgan Industrials Conference - Guidance and capital allocation signals
  • Next quarterly results: Confirmation of margin path after Group reorganization
  • M&A-Updates: Fortive has recently completed acquisitions - further portfolio measures possible
  • Macro: Stabilization in the industrial environment would support demand for measurement technology and automation solutions
These factors can positively influence the company's future growth and performance.

What are the key risks when investing in FTV.NYSE?

Key risks for FTV.NYSE include: Fortive operates across instrumentation, sensing, industrial software, and healthcare sterilization. Its competitive landscape includes large diversified industrials alongside specialist firms in test and measurement, asset-management software, safety and gas detection, and healthcare sterilization. The company faces material headwinds from competitive intensity, technological disruption including AI, integration complexity from acquisitions, elevated leverage, and sensitivity to cyclical demand alongside supply-chain and regulatory friction.
  • Sustained competition across multiple product lines may necessitate price reductions, market share losses, or higher spending on R&D and sales to maintain customer relationships, as Fortive's 10-K filings acknowledge. [web:9]
  • Failure to develop, commercialize, or secure intellectual property protection for emerging technologies—including AI-enabled solutions—could undermine product competitiveness and limit growth prospects. [web:9]
  • Fortive relies heavily on acquisitions as a core strategic lever, though deals carry material risks around execution, balance sheet expansion, and the operational complexity of combining businesses. [web:9]
  • Cyclical swings in end-market demand, supply-chain bottlenecks, and regulatory or healthcare compliance requirements pose material risks to revenue, margins, and operational continuity. [web:9]
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of Fortive Corp?

Fortive Corp competes with several listed peers in its sector. Fortive operates across industrial technology, precision instrumentation, test and measurement, healthcare sterilization, and vertical software. These markets contain both diversified industrials and specialist firms focused on instrumentation and software. Competition mainly comes from large diversified industrial companies and specialist vendors in test/measurement and healthcare equipment. The company faces material risks from supply-chain disruptions and commodity price swings, foreign-exchange and interest-rate movements, regulatory and medical-device compliance requirements, and execution challenges around acquisitions and software integration.
  • Keysight Technologies, Inc. (KEYS.NYSE)
  • Danaher Corporation (DHR.NYSE)
  • AMETEK, Inc. (AME.NYSE)
  • Dover Corporation (DOV.NYSE)
  • Emerson Electric Co. (EMR.NYSE)
  • Teledyne Technologies Incorporated (TDY.NYSE)
  • Roper Technologies, Inc. (ROP.NYSE)
  • Nordson Corporation (NDSN.NASDAQ)
  • IDEX Corporation (IEX.NYSE)
  • Graco Inc. (GGG.NYSE)
These competitors influence pricing power, growth opportunities and relative valuation.

Key Metrics

From recommendation (March 9, 2026)

Market Capitalization
18.53B USD
P/E Ratio
31.65
Analyst Target Price
62.19 USD

Valuation Metrics

P/S Ratio
3.56
P/B Ratio
2.84

Profitability Metrics

Profit Margin
13.93%
Operating Margin
20.13%
Return on Equity
6.40%
Return on Assets
3.13%

Growth Metrics

Revenue Growth
4.60%
Earnings Growth
-2.60%

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20260.07 USD0.12%0.11%
20260.06 USD0.10%
20260.06 USD0.11%
20250.06 USD0.11%
20250.06 USD0.12%
20250.05 USD0.10%
20250.06 USD0.11%
20250.06 USD0.10%
20240.06 USD0.10%
20240.06 USD0.11%
20240.06 USD0.11%
20240.06 USD0.09%
20230.06 USD0.12%
20230.05 USD0.09%
20230.05 USD0.11%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

85.4%
Beat estimate
2.4%
Miss estimate
+6.02%
Avg surprise when beat
-1.69%
Avg surprise when miss

Reports analyzed: 41

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus3.25
Range3.17 – 3.30
15 analysts
Est. growth vs prior: 7.67%
Revisions: 7d ↑1 ↓0 · 30d ↑11 ↓2

Key financial figures

All figures in USD

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue5.14B6.23B6.07B5.83B5.25B
Operating income (EBIT)908.90M1.12B1.13B971.80M831.50M
Net income579.20M832.90M865.80M755.20M608.40M
Free cash flow978.10M1.41B1.25B1.21B911.10M
Total assets11.74B17.02B16.91B15.89B16.47B
Equity6.45B10.19B10.32B9.68B9.51B
Net debt2.83B3.06B1.92B2.71B3.32B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon